Table 5 IC50 value of formulation
From: Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer
Formulation | IC50 value B16 (μM) | IC50 value HeLa (μM) |
|---|---|---|
Plain drug suspension | 0.88 ± 1.03 | 0.92 ± 1.21 |
NLC | 8.97 ± 2.09 | 9.2 ± 1.99 |
NLC in gel | 11.96 ± 1.51 | 11.68 ± 2.21 |